Dana Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.32M Sell
73,169
-1,145
-2% -$130K 0.28% 84
2025
Q1
$7.81M Sell
74,314
-1,915
-3% -$201K 0.28% 84
2024
Q4
$8.17M Sell
76,229
-4,373
-5% -$469K 0.27% 84
2024
Q3
$8.07M Sell
80,602
-9,454
-10% -$946K 0.27% 104
2024
Q2
$7.59M Buy
90,056
+14,210
+19% +$1.2M 0.26% 107
2024
Q1
$5.54M Buy
+75,846
New +$5.54M 0.18% 152
2020
Q4
Sell
-28,699
Closed -$1.71M 312
2020
Q3
$1.71M Sell
28,699
-1,930
-6% -$115K 0.09% 126
2020
Q2
$2.14M Sell
30,629
-2,401
-7% -$168K 0.12% 112
2020
Q1
$1.5M Buy
33,030
+6,460
+24% +$293K 0.09% 124
2019
Q4
$1.73M Sell
26,570
-2,164
-8% -$141K 0.08% 156
2019
Q3
$1.78M Sell
28,734
-267
-0.9% -$16.6K 0.09% 145
2019
Q2
$2.07M Buy
29,001
+2,795
+11% +$199K 0.1% 142
2019
Q1
$2.06M Buy
26,206
+6,286
+32% +$493K 0.1% 153
2018
Q4
$1.69M Buy
19,920
+1,891
+10% +$160K 0.09% 167
2018
Q3
$3.09M Sell
18,029
-3,140
-15% -$538K 0.13% 121
2018
Q2
$2.74M Sell
21,169
-5,710
-21% -$738K 0.12% 127
2018
Q1
$2.77M Sell
26,879
-2,416
-8% -$249K 0.12% 121
2017
Q4
$2.5M Sell
29,295
-966
-3% -$82.5K 0.11% 144
2017
Q3
$2.57M Sell
30,261
-342
-1% -$29K 0.12% 131
2017
Q2
$2.32M Buy
30,603
+718
+2% +$54.4K 0.11% 159
2017
Q1
$1.97M Buy
29,885
+553
+2% +$36.5K 0.09% 188
2016
Q4
$1.86M Buy
29,332
+954
+3% +$60.5K 0.09% 191
2016
Q3
$1.81M Buy
28,378
+614
+2% +$39.1K 0.09% 174
2016
Q2
$2.07M Buy
27,764
+3,296
+13% +$245K 0.09% 165
2016
Q1
$1.64M Buy
24,468
+21,709
+787% +$1.45M 0.07% 160
2015
Q4
$1.72K Sell
2,759
-24,720
-90% -$15.4K 0.08% 149
2015
Q3
$1.47M Sell
27,479
-5,852
-18% -$313K 0.07% 154
2015
Q2
$2.1M Buy
33,331
+5,009
+18% +$315K 0.1% 131
2015
Q1
$1.36M Buy
28,322
+340
+1% +$16.4K 0.07% 144
2014
Q4
$929K Buy
27,982
+1,303
+5% +$43.3K 0.04% 197
2014
Q3
$782K Buy
26,679
+4,894
+22% +$143K 0.05% 196
2014
Q2
$847K Buy
21,785
+202
+0.9% +$7.85K 0.05% 194
2014
Q1
$906K Buy
+21,583
New +$906K 0.06% 163